Literature DB >> 9393774

Role of gamma interferon in natural clearance of Bordetella pertussis infection.

J Barbic1, M F Leef, D L Burns, R D Shahin.   

Abstract

Using a mouse model of Bordetella pertussis infection, we have analyzed the role of gamma interferon (IFN-gamma) in bacterial clearance from the respiratory tract. Adult BALB/c mice began to clear a respiratory infection within 3 weeks postinfection, with complete resolution of infection 6 to 8 weeks postinfection. In contrast, neither adult SCID mice (which lack mature B and T lymphocytes) nor adult nude mice (which lack mature T lymphocytes) controlled B. pertussis infection, and both strains died within 3 to 5 weeks postinfection. Short-term T-cell lines generated from the draining lymph nodes of the lungs of infected BALB/c mice were found to be CD4+ and produced IFN-gamma but no detectable interleukin-4. Analyses of IFN-gamma mRNA induction in the lungs of mice following B. pertussis infection showed that in both BALB/c and C57BL/6 mice, IFN-gamma mRNA levels increased sharply by 1 week postinfection and then subsequently declined. Further exploration of a potential role for IFN-gamma demonstrated that infection of adult BALB/c mice depleted of IFN-gamma in vivo with anti-IFN-gamma monoclonal antibodies resulted in greater numbers of bacteria recovered from the lungs than in infected, control BALB/c mice, although IFN-gamma-depleted mice could subsequently clear the infection. Infection of mice which have a disrupted IFN-gamma gene resulted in bacterial clearance with a time course similar to those seen with IFN-gamma-depleted mice. These results indicate that IFN-gamma plays a role in controlling B. pertussis infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393774      PMCID: PMC175707          DOI: 10.1128/iai.65.12.4904-4908.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.

Authors:  S A Halperin; T B Issekutz; A Kasina
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

2.  The role of interferon-gamma in the induction of activated macrophages.

Authors:  R D Schreiber; A Celada; N Buchmeier
Journal:  Ann Inst Pasteur Immunol (1985)       Date:  1986 Mar-Apr

Review 3.  Mouse respiratory infection models for pertussis.

Authors:  R D Shahin; J L Cowell
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages.

Authors:  A Celada; M J Klemsz; R A Maki
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

5.  Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis.

Authors:  S Peppoloni; L Nencioni; A Di Tommaso; A Tagliabue; P Parronchi; S Romagnani; R Rappuoli; M T De Magistris
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Authors:  A Svetić; F D Finkelman; Y C Jian; C W Dieffenbach; D E Scott; K F McCarthy; A D Steinberg; W C Gause
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

7.  Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.

Authors:  H Sato; A Ito; J Chiba; Y Sato
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Dissecting human T cell responses against Bordetella species.

Authors:  M T De Magistris; M Romano; S Nuti; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

9.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.

Authors:  R D Shahin; M J Brennan; Z M Li; B D Meade; C R Manclark
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  35 in total

Review 1.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Different effects of whole-cell and acellular vaccines on Bordetella transmission.

Authors:  William E Smallridge; Olivier Y Rolin; Nathan T Jacobs; Eric T Harvill
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

3.  The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.

Authors:  Jamie Jennings-Gee; Sally Quataert; Tridib Ganguly; Ralph D'Agostino; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

4.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 5.  Pertussis vaccines and protective immunity.

Authors:  Parul Kapil; Tod J Merkel
Journal:  Curr Opin Immunol       Date:  2019-05-09       Impact factor: 7.486

6.  A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.

Authors:  P McGuirk; K H Mills
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines.

Authors:  Françoise Vermeulen; Virginie Verscheure; Eliane Damis; Danièle Vermeylen; Gaëlle Leloux; Violette Dirix; Camille Locht; Françoise Mascart
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

8.  A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.

Authors:  Ciaran M Skerry; Joseph P Cassidy; Karen English; Pascal Feunou-Feunou; Camille Locht; Bernard P Mahon
Journal:  Clin Vaccine Immunol       Date:  2009-07-22

9.  T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.

Authors:  C M Ausiello; R Lande; P Stefanelli; C Fazio; G Fedele; R Palazzo; F Urbani; P Mastrantonio
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Role of neutrophils in response to Bordetella pertussis infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.